613 related articles for article (PubMed ID: 17284927)
21. Possible induction of oral allergy syndrome during specific immunotherapy in patients sensitive to tree pollen.
Modrzyński M; Zawisza E
Med Sci Monit; 2005 Jul; 11(7):CR351-5. PubMed ID: 15990693
[TBL] [Abstract][Full Text] [Related]
22. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
23. Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy.
Asero R
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):460-2. PubMed ID: 10795656
[TBL] [Abstract][Full Text] [Related]
24. Birch-apple syndrome treated with birch pollen immunotherapy.
Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G
Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
26. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
27. Effect of birch pollen-specific immunotherapy on birch pollen-related hazelnut allergy.
van Hoffen E; Peeters KA; van Neerven RJ; van der Tas CW; Zuidmeer L; van Ieperen-van Dijk AG; Bruijnzeel-Koomen CA; Knol EF; van Ree R; Knulst AC
J Allergy Clin Immunol; 2011 Jan; 127(1):100-1, 101.e1-3. PubMed ID: 20933256
[No Abstract] [Full Text] [Related]
28. Oral allergy syndrome successfully treated with pollen immunotherapy.
Kelso JM; Jones RT; Tellez R; Yunginger JW
Ann Allergy Asthma Immunol; 1995 May; 74(5):391-6. PubMed ID: 7749969
[TBL] [Abstract][Full Text] [Related]
29. Differences among pollen-allergic patients with and without plant food allergy.
Cuesta-Herranz J; Barber D; Blanco C; Cistero-Bahíma A; Crespo JF; Fernández-Rivas M; Fernández-Sánchez J; Florido JF; Ibáñez MD; Rodríguez R; Salcedo G; Garcia BE; Lombardero M; Quiralte J; Rodriguez J; Sánchez-Monge R; Vereda A; Villalba M; Alonso Díaz de Durana MD; Basagaña M; Carrillo T; Fernández-Nieto M; Tabar AI
Int Arch Allergy Immunol; 2010; 153(2):182-92. PubMed ID: 20413986
[TBL] [Abstract][Full Text] [Related]
30. The impact of pollen-related food allergens on pollen allergy.
Bohle B
Allergy; 2007 Jan; 62(1):3-10. PubMed ID: 17156335
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
32. Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations.
Movérare R; Vesterinen E; Metso T; Sorva R; Elfman L; Haahtela T
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):337-42. PubMed ID: 11289336
[TBL] [Abstract][Full Text] [Related]
33. Effects of birch pollen SIT on apple allergy: a matter of dosage?
Asero R
Allergy; 2004 Dec; 59(12):1269-71. PubMed ID: 15507094
[No Abstract] [Full Text] [Related]
34. Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
Kihlström A; Hedlin G; Pershagen G; Troye-Blomberg M; Härfast B; Lilja G
Clin Exp Allergy; 2005 Dec; 35(12):1542-9. PubMed ID: 16393319
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.
Bohle B; Radakovics A; Lüttkopf D; Jahn-Schmid B; Vieths S; Ebner C
Clin Exp Allergy; 2005 Oct; 35(10):1392-9. PubMed ID: 16238801
[TBL] [Abstract][Full Text] [Related]
36. [The effect of specific immunotherapy on serum eotaxin level in patients with pollinosis: preliminary studies].
Jahnz-Rózyk K; Głodzińska-Wyszogrodzka E; Rozyńska-Polańska R; Paluchowska E; Zabielski LS
Pol Merkur Lekarski; 2001 Sep; 11(63):244-6. PubMed ID: 11761820
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal digestion of Bet v 1-homologous food allergens destroys their mediator-releasing, but not T cell-activating, capacity.
Schimek EM; Zwölfer B; Briza P; Jahn-Schmid B; Vogel L; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Dec; 116(6):1327-33. PubMed ID: 16337467
[TBL] [Abstract][Full Text] [Related]
39. Profilin sensitization detected in the office by skin prick test: a study of prevalence and clinical relevance of profilin as a plant food allergen.
Asero R; Monsalve R; Barber D
Clin Exp Allergy; 2008 Jun; 38(6):1033-7. PubMed ID: 18489029
[TBL] [Abstract][Full Text] [Related]
40. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens.
Jahn-Schmid B; Radakovics A; Lüttkopf D; Scheurer S; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Jul; 116(1):213-9. PubMed ID: 15990797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
